跳至主要内容
临床试验/NCT07035847
NCT07035847招募中不适用

Transcatheter Aortic Valve Replacement With Pure Echocardiography Guidance

Chinese Academy of Medical Sciences, Fuwai Hospital1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2024年10月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
20
试验地点
1
主要终点
Valve Academic Research Consortium-3

研究概览

简要总结

This study aims to evaluate the safety and feasibility of performing transaxillary transcatheter aortic valve replacement (TA TAVR) guided solely by echocardiography in patients with severe aortic stenosis (AS).

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

性别
All
接受健康志愿者

入选标准

  • symptomatic severe AS determined by echocardiography and Doppler that requiring aortic valve replacement, defined as: mean gradient ≥40 mmHg, peak aortic velocity ≥4 m/s, and aortic valve area (AVA) ≤1 cm2 (or an indexed AVA ≤0.6 cm2/m2)
  • a history of malignancy or a high familial risk of cancer, with refusal to undergo contrast- or radiation-guided procedures
  • chronic kidney disease and refuse to receive contrast agents or radiation exposure.
  • suitable for Transaxillary TAVR

排除标准

  • required hybrid procedures or concomitant interventions on other cardiac malformations
  • inoperable due to extremely high surgical risk or severe comorbidities
  • untreated clinically significant (>70% obstruction) proximal vessel coronary vascular disease amenable to revascularization
  • previously undergone aortic valve replacement.

研究组 & 干预措施

Echo guided TAVR

Experimental

Patients received Echocardiography guided TAVR

干预措施: Echocardiography guided TAVR (Procedure)

结局指标

主要结局

Valve Academic Research Consortium-3

时间窗: 30 days after intervention

Outcomes were reported according to the VARC-3 criteria.Which include: Technical success: Evaluated immediately post-procedure (e.g., successful vascular access, device delivery, deployment, no immediate complications). Device success: Includes successful valve function with acceptable hemodynamics and positioning. Procedural success: Includes 30-day outcomes, combining technical/device success and absence of major complications.

次要结局

未报告次要终点

研究者

发起方
Chinese Academy of Medical Sciences, Fuwai Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Pan Xiangbin

Principle Investigator

Chinese Academy of Medical Sciences, Fuwai Hospital

研究点 (1)

Loading locations...

相似试验